Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

595 trials

NCT06066359
Recruiting
Ph I/II Trial of Cord Blood-derived NK Cells With NY-ESO-1 TCR/IL-15 for R/R Myeloma
Phase 1/2 · United States · 1 site
Registry update: 5 Oct 2026
NCT06616389
Recruiting
Study of ODX (OsteoDex) in Multiple Myeloma
Phase 1/2 · Sweden · 2 sites
Registry update: 19 Aug 2025
NCT06158412
Recruiting
All-trans Retinoic Acid in Combination With a KPD Regimen for the Treatment of Refractory/Relapsed Multiple Myeloma
Phase 2 · China · 1 site
Registry update: 19 Feb 2025
NCT06039735
Recruiting
Cardiac Toxicity and Prognostic Value of New Echocardiographic Indicators in the Treatment of Primary Multiple Myeloma
Not applicable · China · 1 site
Registry update: 21 Nov 2023
NCT05583617
Recruiting
A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma
Phase 1/2 · Australia, Germany, Spain, France, South Korea, Poland · 17 sites
Registry update: 5 Nov 2026
NCT06246162
Recruiting
Mitoxantrone Hydrochloride Liposome Combination Regimen in the Treatment of High-risk/Extramedullary Multiple Myeloma
Phase 1/2 · China · 1 site
Registry update: 7 Feb 2024
NCT06132711
Recruiting
Safety and Efficacy of APRIL-BAFF-Bicephali CAR-T in Relapsed, Refractory Multiple Myeloma
Phase 1/2 · China · 1 site
Registry update: 15 Nov 2023
NCT05862012
Recruiting
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
Phase 1 · Australia, Spain, France, India, Italy, Norway, United States · 34 sites
Registry update: 1 Apr 2026
NCT06182696
Recruiting
OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMM
Phase 1/2 · China · 5 sites
Registry update: 31 May 2024
NCT06895291
Recruiting
Whole Body MRI in Oncology
Not applicable · Italy · 3 sites
Registry update: 30 Mar 2025
NCT06119685
Recruiting
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
Phase 1/2 · United States · 12 sites
Registry update: 3 Jun 2025
NCT05972135
Recruiting
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Phase 2 · United States · 17 sites
Registry update: 22 Apr 2026
NCT06049290
Recruiting
A Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma
Phase 1/2 · China · 21 sites
Registry update: 11 Sept 2026
NCT06140966
Recruiting
Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma
Phase 2 · China · 1 site
Registry update: 16 Apr 2025
NCT05879757
Recruiting
Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
Not applicable · Argentina, Czechia, Germany, Spain, France, Greece, Italy, Poland, Romania, Sweden · 27 sites
Registry update: 18 Feb 2026
NCT06083922
Recruiting
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Phase 2 · United States · 11 sites
Registry update: 6 Jul 2026
NCT05561387
Recruiting
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Phase 3 · United States · 397 sites
Registry update: 10 Jun 2026
NCT06357754
Recruiting
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
Not applicable · Switzerland, Germany, Japan, United States · 8 sites
Registry update: 22 Jan 2026
NCT06057402
Recruiting
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
Phase 4 · Australia, Canada, China, Germany, Spain, France, Japan, Taiwan, United States · 39 sites
Registry update: 1 Jul 2026
NCT06087653
Recruiting
Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM)
Phase 1/2 · United States · 2 sites
Registry update: 24 Aug 2026

Ordered by registry start date. Freshness and sponsorship never change the order.